Does RUXOLITINIB Cause Thrombocytopenia? 1,654 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,654 reports of Thrombocytopenia have been filed in association with RUXOLITINIB (OPZELURA). This represents 2.4% of all adverse event reports for RUXOLITINIB.
1,654
Reports of Thrombocytopenia with RUXOLITINIB
2.4%
of all RUXOLITINIB reports
344
Deaths
600
Hospitalizations
How Dangerous Is Thrombocytopenia From RUXOLITINIB?
Of the 1,654 reports, 344 (20.8%) resulted in death, 600 (36.3%) required hospitalization, and 114 (6.9%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for RUXOLITINIB.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which RUXOLITINIB Alternatives Have Lower Thrombocytopenia Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE